Bigflex Lifescience Private Limited - Due diligence report

A 360° intelligence report on Bigflex Lifescience: trust score, financial health, credit view, compliance, directors, growth and distress si…

2019-02-28 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bigflex Lifescience — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Bigflex Lifescience is assessed as Low Risk with a Trust Score of 76/100. Bigflex Lifescience is an active private limited indian non-government company incorporated in 2019, operating in the E-Commerce sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Bigflex Lifescience Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ADARSH RAJENDRA SOMANI 01234567 Director 01/04/2018 6 yrs Approved
BAL MUKAND GAGGAR 01234567 Director 01/04/2018 6 yrs Approved
PRASHANT GOPAL MANTRI 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Kopran Lifestyle Limited
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Kopran Lifestyle Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 75
Growth signals & trust indicators
Operating for 7 years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
07 Jul 2023
Director appointed
PRASHANT GOPAL MANTRI (Director)
23 Jun 2023
Director ceased
SANJEEV AGRAWAL
19 Oct 2022
Securities allotted
10000 Preference Shares - 50.00 Lakh raised
Securities allotted
25000 Preference Shares - 1.25 cr raised
Securities allotted
65000 Preference Shares - 3.25 cr raised
26 Sep 2022
Director ceased
PRASHANT GOPAL MANTRI
25 Sep 2022
Securities allotted
149000 Equity Shares - 1.49 cr raised
18 Dec 2021
Securities allotted
700000 Preference Shares - 7.00 cr raised
28 Feb 2019
Incorporated
Registered with Roc Mumbai
Director appointed
ADARSH RAJENDRA SOMANI (Director)
Director appointed
BAL MUKAND GAGGAR (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
ARDI FINCAP LLP AAR-9429 Mumbai, Maharashtra
Lodha Pinnacle Buildtech And Farms Private Limited U45201MH2007PTC166670 Mumbai, Maharashtra
Taproot Dentsu India Communication Private Limited U74999MH2011PTC217524 Mumbai, Maharashtra
Chemicorp Specialities India Private Limited U74110MH1992PTC067520 Mumbai, Maharashtra
Drishyavalok Technologies Private Limited U80100MH2024PTC430633 Mumbai, Maharashtra
Microlink Adaptive Technologies India Private Limited U32509MH2023FTC408808 Mumbai, Maharashtra
Frenzy Finance Private Limited U65923MH1996PTC096379 Mumbai, Maharashtra
Ital Pharchem Private Limited U51101MH2012PTC236003 Mumbai, Maharashtra
SITA AGENCIES AND TRADING LLP AAE-0908 Mumbai, Maharashtra
J M Township And Real Estate Private Limited. U45201MH2006PTC166516 Mumbai, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bigflex Lifescience before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bigflex Lifescience: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Bigflex Lifescience - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Bigflex Lifescience pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bigflex Lifescience - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bigflex Lifescience an active company?

Bigflex Lifescience has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Bigflex Lifescience financially healthy?

Bigflex Lifescience has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Bigflex Lifescience?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bigflex Lifescience?

The ultimate holding entity is Kopran Lifestyle Limited. 3 active director(s) are on record.

Does Bigflex Lifescience have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Bigflex Lifescience up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Bigflex Lifescience?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.